Suppr超能文献

甲状腺激素敏感性与多囊卵巢综合征风险的相关性。

Correlation between thyroid hormone sensitivity and the risk of polycystic ovary syndrome.

机构信息

Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, China.

出版信息

BMC Endocr Disord. 2024 May 30;24(1):76. doi: 10.1186/s12902-024-01607-3.

Abstract

OBJECTIVE

There has been some confusion in earlier research on the connection between thyroid function and polycystic ovary syndrome (PCOS). This research is aimed to probe into the correlation between thyroid condition and the risk of PCOS from a new standpoint of thyroid hormone sensitivity.

METHODS

This research comprised 415 females with PCOS from Drum Tower Hospital Affiliated with the Medical School of Nanjing University, and 137 non-PCOS individuals were selected as the normal control. Based on free thyroxine (FT4), free triiodothyronine (FT3), and thyroid-stimulating hormone (TSH), we calculated the thyroid hormone sensitivity indices, which consist of Thyroid Feedback Quantile-based Index (TFQI), Thyroid-stimulating Hormone Index (TSHI), Thyrotroph Thyroxine Resistance Index (TT4RI) and Free Triiodothyronine /Free thyroxine (FT3/FT4). The binary logistic regression model was adopted to investigate the correlation between thyroid hormone sensitivity indices with the risk of PCOS. Pearson or Spearman correlation analysis was employed to explore the association among thyroid-related measures with metabolic parameters in PCOS.

RESULTS

Results of this research showed that females with PCOS had rising TFQI, TSHI, TT4RI, and FT3/FT4 levels compared with the control group. After adjustment for the impact of various covariates, there was no significant correlation between FT3/FT4 and the risk of PCOS; However, the odds ratio of the third and fourth vs. the first quartile of TFQI were 3.57(95% confidence interval [CI]:1.08,11.87) and 4.90(95% CI:1.38,17.38) respectively; The odds ratio of the fourth vs. the first quartile of TSHI was 5.35(95% CI:1.48,19.37); The odds ratio of the second vs. the first quartile of TT4RI was 0.27(95%CI 0.09,0.82). In addition, no significant correlation was observed between thyroid-related measures and metabolic measures in females with PCOS.

CONCLUSIONS

A reduction in the sensitivity of central thyroid hormone is closely correlated with a higher risk of PCOS. Further research is necessary to corroborate our findings and the supporting mechanisms.

摘要

目的

甲状腺功能与多囊卵巢综合征(PCOS)之间的联系在早期研究中存在一些混淆。本研究旨在从甲状腺激素敏感性的新角度探讨甲状腺状况与 PCOS 风险之间的相关性。

方法

本研究纳入了来自南京大学医学院附属鼓楼医院的 415 名 PCOS 女性患者,并选择了 137 名非 PCOS 个体作为正常对照组。基于游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)和促甲状腺激素(TSH),我们计算了甲状腺激素敏感性指数,包括甲状腺反馈定量指数(TFQI)、促甲状腺激素指数(TSHI)、促甲状腺激素甲状腺素抵抗指数(TT4RI)和游离三碘甲状腺原氨酸/游离甲状腺素(FT3/FT4)。采用二元逻辑回归模型探讨甲状腺激素敏感性指数与 PCOS 风险的相关性。采用 Pearson 或 Spearman 相关分析探讨 PCOS 患者甲状腺相关指标与代谢参数之间的关系。

结果

研究结果显示,与对照组相比,PCOS 女性的 TFQI、TSHI、TT4RI 和 FT3/FT4 水平升高。在调整了各种混杂因素的影响后,FT3/FT4 与 PCOS 风险之间没有显著相关性;然而,TFQI 第三和第四四分位与第一四分位的比值分别为 3.57(95%置信区间[CI]:1.08,11.87)和 4.90(95% CI:1.38,17.38);TSHI 第四四分位与第一四分位的比值为 5.35(95% CI:1.48,19.37);TT4RI 第二四分位与第一四分位的比值为 0.27(95%CI 0.09,0.82)。此外,在 PCOS 女性中,甲状腺相关指标与代谢指标之间没有显著相关性。

结论

中央甲状腺激素敏感性降低与 PCOS 风险增加密切相关。需要进一步研究来证实我们的发现和支持机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1839/11137887/5953968e344b/12902_2024_1607_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验